• LAST PRICE
    18.4600
  • TODAY'S CHANGE (%)
    Trending Down-0.3400 (-1.8085%)
  • Bid / Lots
    18.4000/ 1
  • Ask / Lots
    18.4600/ 2
  • Open / Previous Close
    18.8600 / 18.8000
  • Day Range
    Low 18.3250
    High 19.2700
  • 52 Week Range
    Low 3.6000
    High 28.1500
  • Volume
    97,952
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 18.8
TimeVolumeLBPH
09:32 ET207918.77
09:34 ET20118.995
09:38 ET10019.27
09:39 ET20019.035
09:41 ET550018.8865
09:43 ET40218.635
09:50 ET203618.96
09:52 ET49218.9
09:54 ET10018.86
09:56 ET20018.79
09:57 ET10018.78
09:59 ET10018.84
10:01 ET10018.83
10:03 ET20018.7
10:06 ET250018.42
10:08 ET240618.4325
10:10 ET343418.5
10:12 ET80518.475
10:14 ET10018.475
10:15 ET362418.68
10:17 ET10018.705
10:19 ET41218.65
10:21 ET70018.675
10:24 ET240018.645
10:26 ET416518.62
10:28 ET132418.63
10:30 ET23818.68
10:32 ET90018.55
10:35 ET10018.65
10:37 ET121418.61
10:44 ET558918.535
10:46 ET60018.48
10:53 ET10018.5
10:55 ET10018.385
10:57 ET10018.51
11:04 ET20018.455
11:06 ET30018.47
11:08 ET10018.47
11:09 ET120018.405
11:11 ET90018.35
11:15 ET20018.44
11:18 ET21018.44
11:20 ET20018.56
11:22 ET20018.55
11:26 ET20018.57
11:27 ET10018.585
11:33 ET57518.65
11:36 ET10018.625
11:38 ET180018.49
11:42 ET100018.44
11:44 ET30018.43
11:49 ET10018.395
11:51 ET10018.4
11:54 ET10018.445
11:58 ET118718.44
12:00 ET24218.44
12:03 ET64618.44
12:05 ET40018.44
12:07 ET10018.44
12:09 ET10018.455
12:12 ET10018.455
12:14 ET130018.46
12:20 ET90018.46
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLBPH
Longboard Pharmaceuticals Inc
730.9M
-8.2x
---
United StatesGHRS
GH Research PLC
712.8M
-20.8x
---
United StatesLYEL
Lyell Immunopharma Inc
706.2M
-3.1x
---
United StatesNUVB
Nuvation Bio Inc
761.3M
-9.8x
---
United StatesPRAX
Praxis Precision Medicines Inc
754.1M
-2.8x
---
United StatesVRDN
Viridian Therapeutics Inc
772.9M
-2.7x
---
As of 2024-05-28

Company Information

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for neurological diseases. The Company is working to advance a portfolio of centrally acting product candidates designed to be highly selective for specific G protein-coupled receptors (GPCRs). It is focused on developing various product candidates in its pipeline, which includes bexicaserin (LP352) and LP659. The Company plans to advance bexicaserin (LP352), an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with no observed impact on 5-HT2B and 5-HT2A receptor subtypes, into a global Phase 3 program. It is also evaluating LP659, an oral, centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, which is in development for the potential treatment of rare neuroinflammatory conditions. The Company is conducting a Phase 1 single-ascending dose (SAD) clinical trial for LP659 in healthy volunteers.

Contact Information

Headquarters
4275 Executive Square, Suite 950LA JOLLA, CA, United States 92037
Phone
619-592-9775
Fax
302-636-5454

Executives

Independent Chairman of the Board
Paul Sekhri
President, Chief Executive Officer, Director
Kevin Lind
Chief Financial Officer, Executive Vice President
Brandi Roberts
Executive Vice President, Chief Medical Officer
Randall Kaye
Independent Director
Vincent Aurentz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$730.9M
Revenue (TTM)
$0.00
Shares Outstanding
38.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.25
Book Value
$1.67
P/E Ratio
-8.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.